Gyros Protein Technologies, which provides automated nanoliter-scale immunoassays, peptide synthesizers, and reagents, appointed Abacus as exclusive distributor of its immunoassay products in Australia and New Zealand.

“Abacus ALS has a proven track record with over fifty years of experience in building successful partnerships and providing excellent service and technical support in the region,” said Peter Luk, vp, Asia-Pacific, Gyros Protein Technologies. “This strong market presence and reputation make them an ideal distribution partner for our immunoassay products. We are pleased to be working with Abacus ALS to build our network of customers in Australia and New Zealand.”

Previous articleRoche Terminates SMRT Sequencing Partnership with PacBio
Next articleTakara Bio to Acquire Rubicon Genomics